Effect of transforming growth factor-β1 on the insulin-like growth factor system in cultured porcine Leydig cells

doi:10.1016/0303-7207(94)90015-9

Molecular and Cellular Endocrinology

Volume 99, Issue 2, March 1994, Pages 251-257

https://doi.org/10.1016/0303-7207(94)90015-9 Get rights and content

Abstract

Using as a model system, primary cultures of porcine Leydig cells, we have shown that transforming growth factor-beta 1 (TGF-β₁) (2 ng/ml, 72 h) antagonizes the stimulatory action of insulin-like growth factor-I (IGF-I) on luteinizing hormone (LH/hCG) receptors. We therefore investigated the action of TGF-β₁ on the different components of the IGF system, namely, IGF-I, II, IGF binding proteins (IGFBPs) and IGF-I receptor present in testicular Leydig cells. TGF-β₁ was shown to decrease in a dose and time dependent manner the binding of ¹²⁵I-IGF-I to Leydig cells. The maximal (40% decrease) effect was obtained with 1.3 ng/ml (0.05 nM) after 72 h of treatment. Such a decrease in IGF-I binding by TGF-β₁ treatment was shown to be related to the number of receptor but not to their affinity. Affinity labeling of these receptors by covalently binding them to ¹²⁵I-IGF-I with disuccinimidyl suberate and subsequent electrophoretic analysis of the labeled complex revealed that the inhibitory action of TGF-β₁ (2 ng/ml, 72 h) occurs at the level of a 135 kDa protein which represents the classical form of the binding subunit of the IGF-I receptor. Moreover, our study indicates that TGF-β₁ was unable to affect the other components of the IGF system in cultured porcine Leydig cells. Indeed, TGF-β₁ (2 ng/ml, 72 h) was without effect on immunoreactive IGF-I and IGF-II secretion and also on the different IGF binding proteins (IGFBPs) (44, 40, 34, 29, and 24 kDa) as evaluated by ligand blotting analysis. Together, our findings clearly suggest that in Leydig cells TGF-β₁ reduces IGF-I action probably by decreasing IGF-I receptor levels but not by affecting the other components of the IGF system. Such a decrease in IGF-I receptors may provide an explanation for the antagonistic effect of TGF-β₁ on IGF-I action in Leydig cells.

References (41)

M. Benahmed et al.
Mol. Cell. Endocrinol.
(1987)
M. Benahmed et al.
Biochem. Biophys. Res. Commun.
(1988)
M. Benahmed et al.
Mol. Cell. Endocrinol.
(1989)
J. Cailleau et al.
Mol. Cell. Endocrinol.
(1990)
K.J. Catt et al.
S.E. Jacobsen et al.
Blood
(1991)
H.Y. Lin et al.
T.C.B.
(1993)
T. Lin et al.
Biochem. Biophys. Res. Commun.
(1987)
T. Lin et al.
Mol. Cell. Endocrinol.
(1990)
A.M. Morera et al.
J. Steroid Biochem.
(1988)

H.L. Moses et al.

Cell

(1990)

E.Y. Adashi et al.

Endocrinology

(1988)

A.R. Bellvé et al.

J. Reprod. Fertil.

(1989)

M. Benahmed et al.

M. Binoux et al.

J. Clin. Endocrinol. Metab.

(1984)

J.P. Bourguignon et al.

Clin. Endocr.

(1993)

E. Canalis et al.

Endocrinology

(1991)

W.H. Daughaday et al.

J. Clin. Endocrinol. Metab.

(1980)

C.M. Dubois et al.

J. Exp. Med.

(1990)

P. Hossenlop et al.

Anal. Biochem.

(1986)

Cited by (6)

The insulin-like growth factor (IGF) system and gonadotropin regulation: Actions and interactions
1999, Cytokine and Growth Factor Reviews
Insulin-like growth factors (IGF) are polypeptides that regulate growth, differentiation and survival in a multitude of cells and tissues. The IGF system consists of ligands, receptors, binding proteins and binding protein proteases. The influence of the IGF system on reproductive parameters, specifically gonadotropin release and interactions between the IGF system and other effectors of gonadotropin release will be examined in this review.
Human glomerular endothelial cells IGFBPs are regulated by IGF-I and TGF-β<inf>1</inf>
1999, Molecular and Cellular Endocrinology
The release of insulin-like growth factor binding proteins (IGFBPs) and their regulation in human glomerular endothelial cells (GENC) was characterised. GENC produce IGFBP-4, IGFBP-2 and IGFBP-3 and express mRNA for IGFBP-2 to IGFBP-5. Due to the fact that IGF-I and TGF-β₁ modulate glomerular hypertrophy, their action on IGFBP release and GENC growth was studied. IGF-I increased IGFBP-3, IGFBP-2 and decreased IGFBP-4, while TGF-β₁ decreased IGFBP-3 and apparently increased IGFBP-4. All of the IGFBPs, except the TGF-β₁-regulated IGFBP-4, were modulated at mRNA level. IGF-I stimulated GENC proliferation, while TGF-β₁ inhibited their growth. It was demonstrated that an IGFBP-3 antibody reduced GENC proliferation. However, rhIGFBP-3 alone had no effect on GENC, but after 48 h pre-incubation the IGF-I stimulated GENC growth was increased, suggesting that IGFBP-3 could modulate the IGF-I induced GENC proliferation. It was concluded that the stimulatory IGFBP-3 and the inhibitory IGFBP-4 could regulate GENC growth, although the IGFBP-3 seems to have a predominant effect in this control.
Transforming growth factor-β receptor types I and II in cultured porcine Leydig cells: Expression and hormonal regulation
2000, Endocrinology
Seminal transforming growth factor-β in normal and infertile men
1999, Human Reproduction
Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma
1997, Hormone and Metabolic Research
Tumor Necrosis Factor α Stimulates Insulin-Like Growth Factor Binding Protein 3 Expression in Cultured Porcine Sertoli Cells
1996, Endocrinology

View full text

Research paperEffect of transforming growth factor-β1 on the insulin-like growth factor system in cultured porcine Leydig cells

Abstract

Mol. Cell. Endocrinol.

Biochem. Biophys. Res. Commun.

Mol. Cell. Endocrinol.

Mol. Cell. Endocrinol.

Blood

T.C.B.

Biochem. Biophys. Res. Commun.

Mol. Cell. Endocrinol.

J. Steroid Biochem.

Cell

Endocrinology

J. Reprod. Fertil.

J. Clin. Endocrinol. Metab.

Clin. Endocr.

Endocrinology

J. Clin. Endocrinol. Metab.

J. Exp. Med.

Anal. Biochem.

Research paper
Effect of transforming growth factor-β₁ on the insulin-like growth factor system in cultured porcine Leydig cells